English
español
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10261/110067
Share/Impact:
Statistics |
![]() ![]() ![]() |
|
|
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |||
|
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Alba-Castellón, L. | - |
dc.contributor.author | Loubat, Jordina | - |
dc.contributor.author | Muñoz Terol, Alberto | - |
dc.contributor.author | Bonilla, Félix | - |
dc.contributor.author | Casal, J. Ignacio | - |
dc.contributor.author | García de Herreros, Antonio | - |
dc.date.issued | 2014-05 | - |
dc.identifier.citation | Neoplasia 16(5): 413–421 (2014) | es_ES |
dc.identifier.issn | 1522-8002 | - |
dc.identifier.uri | http://hdl.handle.net/10261/110067 | - |
dc.description | Under a Creative Commons license.-- et al. | es_ES |
dc.description.abstract | Snail1 transcriptional repressor is a major inducer of epithelial-to mesenchymal transition but is very limitedly expressed in adult animals. We have previously demonstrated that Snail1 is required for the maintenance of mesenchymal stem cells (MSCs), preventing their premature differentiation. Now, we show that Snail1 controls the tumorigenic properties of mesenchymal cells. Increased Snail1 expression provides tumorigenic capabilities to fibroblastic cells; on the contrary, Snail1 depletion decreases tumor growth. Genetic depletion of Snail1 in MSCs that are deficient in p53 tumor suppressor downregulates MSC markers and prevents the capability of these cells to originate sarcomas in immunodeficient SCID mice. Notably, an analysis of human sarcomas shows that, contrarily to epithelial tumors, these neoplasms display high Snail1 expression. This is particularly clear for undifferentiated tumors, 9which are associated with poor outcome. Together, our results indicate a role for Snail1 in the generation of sarcomas. | es_ES |
dc.description.sponsorship | This study was funded by grants awarded by la Fundación Científica de la Asociación Española contra el Cáncer (to A.G.H., J.I.C., and F.B.), Fundación Sandra Ibarra and Ministerio de Ciencia y Tecnología (SAF2010-16089) to A.G.H. and also by RD12/0036/0005, part of “Plan Nacional de I+D+I” and cofunded by “Instituto de Salud Carlos III (ISCIII)-Subdirección General de Evaluación and Fondo Europeo de Desarrollo Regional (FEDER)”. We also acknowledge support from Fundació La Marató de TV3 (120130), to A.G.H., ISCIII/FEDER (RD12/0036/041, RD12/0036/051, and RD12/0036/021), Generalitat de Catalunya (2009SGR867 and 2009SGR321; Xarxa de Bancs de Tumors), CAM (CAM S2010-BMD2344-Colomics2), and Fundació Cellex (Barcelona). R.B. and L.A.-C. were recipients from “Formación de Personal Investigador” predoctoral fellowships. | - |
dc.language.iso | eng | es_ES |
dc.publisher | Elsevier | es_ES |
dc.relation | S2010-BMD2344-COLOMICS2 | - |
dc.relation.isversionof | Publisher's version | - |
dc.rights | openAccess | es_ES |
dc.title | Snail1 expression is required for sarcomagenesis | es_ES |
dc.type | artículo | es_ES |
dc.identifier.doi | 10.1016/j.neo.2014.05.002 | - |
dc.description.peerreviewed | Peer reviewed | es_ES |
dc.relation.publisherversion | http://dx.doi.org/10.1016/j.neo.2014.05.002 | es_ES |
dc.identifier.e-issn | 1476-5586 | - |
dc.rights.license | http://creativecommons.org/licenses/by-nc-nd/3.0/ | es_ES |
dc.contributor.funder | Comunidad de Madrid | - |
dc.contributor.funder | Fundación Científica Asociación Española Contra el Cáncer | - |
dc.contributor.funder | Fundación Sandra Ibarra - Solidaridad Frente al Cáncer | - |
dc.contributor.funder | Ministerio de Ciencia y Tecnología (España) | - |
dc.contributor.funder | Instituto de Salud Carlos III | - |
dc.contributor.funder | Fundació La Marató de TV3 | - |
dc.contributor.funder | European Commission | - |
dc.contributor.funder | Fundació Privada Cellex | - |
dc.contributor.funder | Generalitat de Catalunya | - |
dc.contributor.funder | Consejo Superior de Investigaciones Científicas (España) | - |
dc.relation.csic | Sí | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/501100002704 | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/501100007649 | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/501100006280 | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/501100004587 | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/100008666 | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/501100000780 | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/501100002809 | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/501100003339 | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/100012818 | es_ES |
Appears in Collections: | (IIBM) Artículos (CIB) Artículos |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Neoplasia 2014, 16 (5) 413-421 J. Ignacio Casal.pdf | 3,48 MB | Adobe PDF | ![]() View/Open |
Show simple item record
Related articles:
WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.